Sleep.ai raises $5.3M to sell device-agnostic sleep intelligence

Sleep.ai has raised $5.3 million to expand its AI-based predictive health models, push deeper into Germany and other markets, and build new partner integrations. The round, announced on November 11, 2026, was led by Treasure Coast Ventures, with participation from the Harvard Business School Alumni Angels of Greater NY and other investors.

The bet behind the money is simple to state: sleep intelligence sold as software, not tied to any single device. Sleep.ai says it has collected and analyzed more than 1.1 billion hours of real-world sleep data, measured longitudinally — night after night, in people's homes — comprising over 200 billion data points. The company also counts 104 scientific publications behind its platform.

That dataset is the asset. The question is whether partners will pay to build on it.

Why the round follows an earlier one

This is the second time Treasure Coast Ventures has led money into the company in roughly 14 months. On August 26, 2025, the firm led a separate $5.5 million round, announced alongside the company's rebrand from SleepScore Labs to Sleep.ai. At that point, the company put its proprietary sleep-data base at more than 800 million hours.

Since then, the dataset has grown by roughly 300 million hours. The new financing funds the next phase: new partner integrations, international expansion with Germany as the anchor, and continued development of predictive health models built on that longitudinal data.

What problem does device-agnostic sleep data solve?

Consumer sleep tracking has a consistency problem, and Sleep.ai has put a number on it. The company's analysis of real-world data found typical gaps of 57 to 89 minutes when different wearable brands measured identical sleep, depending on the brand.

That's the mechanism the platform targets. Sleep.ai normalizes readings across device types and works with data from approximately 800 wearables. The aim is to give enterprise customers consistent sleep scoring regardless of which hardware their users choose.

Robert Padulo, managing partner at Treasure Coast Ventures, framed that hardware independence as the core of the platform's scalability: its reach is not limited by one company's hardware sales. In plain terms, partners can add sleep features without forcing their customers to standardize on one wearable.

The platform doesn't require a wearable at all. Sleep.ai says its smartphone-based measurements include sonar that records no audio, and that the platform can recognize patterns indicative of sleep-disorder risk, including sleep apnea. Partners embed the technology through APIs and SDKs — the software interfaces and toolkits that let them deliver sleep guidance whether or not users own a device.

The takeaway: Sleep.ai is selling the measurement layer, and letting partners choose the hardware.

How does Germany's reimbursed program work?

Sleep.ai's clearest commercial proof point is Dein Schlaf ("Your Sleep"), a nationally reimbursed prevention program certified by Germany's Central Prevention Testing Board. It is available without a prescription to anyone covered by German statutory health insurance — approximately 74 million people.

Participating insurers include:

• BARMER
• AOK Niedersachsen
• IKK Brandenburg und Berlin
• BERGISCHE Krankenkasse

Enrollment has reached 25,000 participants in 2026.

A March 13, 2026 program announcement described Dein Schlaf as a 12-week course with three components: contactless sleep tracking, personalized digital coaching informed by nightly data and individual goals, and adaptive behavioral guidance. The infrastructure is compliant with the EU's General Data Protection Regulation, and participants receive a digital completion certificate used for reimbursement under Germany's prevention guidelines.

Dr. Frederike Escher-Brecht, head of digital product development at BARMER, said the app's reliance on individually measured sleep data distinguishes it from general prevention advice, because each recommendation is based on measured sleep. The program shows how those measurements can be delivered as an institutional health benefit through an insurer.

What results does the program report?

Sleep.ai reports outcomes from users who tracked their sleep for 36 nights. Two in three improved on at least two objective sleep measures compared with their own first week. Those users slept about 30 minutes longer per night and improved their sleep-quality metrics.

Progress came quickly for most. Within that group:

• More than half showed progress by night 14
• Nine in ten did so by night 28

These are self-reported company figures rather than peer-reviewed trial results, but they're the numbers the company is carrying into its expansion pitch. The pattern — measurable improvement within four weeks — is what makes the program repeatable as a reimbursed benefit elsewhere.

Why the market stakes matter

Sleep tracking is fragmented across hardware brands, and health systems want measurable prevention programs they can reimburse. Sleep.ai sits at the junction of both pressures: it normalizes data across roughly 800 wearables while running a certified, insurer-backed program in Europe's largest health market.

That combination is rare. Most sleep-data companies are tied to their own devices or apps. Sleep.ai's 104 publications and 1.1 billion hours of longitudinal data give it scientific and commercial infrastructure that's hard to replicate quickly.

What comes next?

The round ties Sleep.ai's next phase to two connected business questions: whether partners will adopt a common sleep-intelligence layer across fragmented devices, and whether reimbursed prevention can support expansion beyond Germany.

The company now holds two hard assets — a large longitudinal dataset and a reimbursed German deployment channel reaching tens of millions of insured people. Converting those assets into broader partner adoption is the commercial test ahead, and the $5.3 million buys the runway to attempt it.